Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome

Cell Metabolism

Volumn 28, Issue 5, 2018, Pages 737-749.e4

  Natividad, Jane M ^a   Agus, Allison ^a   Planchais, Julien ^a   Lamas, Bruno ^a,b   Jarry, Anne Charlotte ^c   Martin, Rebeca ^a   Michel, Marie Laure ^a   Chong Nguyen, Caroline ^c   Roussel, Ronan ^d,e   Straube, Marjolene ^b   Jegou, Sarah ^b   McQuitty, Claire ^b   Le Gall, Maude ^c   da Costa, Gregory ^a   Lecornet, Emmanuelle ^f   Michaudel, Chloé ^a   Modoux, Morgane ^a,b   Glodt, Jeremy ^a   Bridonneau, Chantal ^a   Sovran, Bruno ^a   Dupraz, Louise ^a,b   Bado, Andre ^c   Richard, Mathias L ^a   Langella, Philippe ^a   Hansel, Boris ^d,e   Launay, Jean Marie ^g   Xavier, Ramnik J ^h,i,j   Duboc, Henri ^c   Sokol, Harry ^a,b,d   more..

^a UNIVERSITÉ PARIS SACLAY   (France)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

more..

Author keywords

AhR; high fat diet; L. reuteri; metabolites; microbiota; ob ob mice

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; GLUCAGON LIKE PEPTIDE 1; INCRETIN; INTERLEUKIN 22; TRIACYLGLYCEROL; LIGAND; PROBIOTIC AGENT; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BODY MASS; BODY WEIGHT GAIN; COLON CONTENT; CONTROLLED STUDY; FATTY LIVER; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; IN VITRO STUDY; INSULIN SENSITIVITY; INTESTINE FLORA; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; TRYPTOPHAN METABOLISM; ANIMAL; C57BL MOUSE; LACTOBACILLUS REUTERI; METABOLISM; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; LACTOBACILLUS REUTERI; LIGANDS; MALE; METABOLIC SYNDROME; MICE; MICE, INBRED C57BL; PROBIOTICS; RECEPTORS, ARYL HYDROCARBON; TRYPTOPHAN;

EID: 85056004239     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2018.07.001     Document Type: Article

References (45)

1. Blacher, E., Levy, M., Tatirovsky, E., Elinav, E., Microbiome-modulated metabolites at the interface of host immunity. J. Immunol. 198 (2017), 572–580.
2. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
3. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
4. + T cells. Science 357 (2017), 806–810.
5. Chimerel, C., Emery, E., Summers, D.K., Keyser, U., Gribble, F.M., Reimann, F., Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 9 (2014), 1202–1208.
6. Crane, J.D., Palanivel, R., Mottillo, E.P., Bujak, A.L., Wang, H., Ford, R.J., Collins, A., Blümer, R.M., Fullerton, M.D., Yabut, J.M., et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat. Med. 21 (2015), 166–172.
7. Ding, S., Lund, P.K., Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 14 (2011), 328–333.
8. Drucker, D.J., Jin, T., Asa, S.L., Young, T.A., Brubaker, P.L., Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol. Endocrinol. 8 (1994), 1646–1655.
9. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
10. Esser, C., The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochem. Pharmacol. 77 (2009), 597–607.
11. Everard, A., Cani, P.D., Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27 (2013), 73–83.
12. Fernandez-Salguero, P., Pineau, T., Hilbert, D.M., McPhail, T., Lee, S.S., Kimura, S., Nebert, D.W., Rudikoff, S., Ward, J.M., Gonzalez, F.J., Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 (1995), 722–726.
13. Furue, M., Takahara, M., Nakahara, T., Uchi, H., Role of AhR/ARNT system in skin homeostasis. Arch. Dermatol. Res. 306 (2014), 769–779.
14. Garner, C.E., Smith, S., de Lacy Costello, B., White, P., Spencer, R., Probert, C.S., Ratcliffe, N.M., Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 21 (2007), 1675–1688.
15. Gulhane, M., Murray, L., Lourie, R., Tong, H., Sheng, Y.H., Wang, R., Kang, A., Schreiber, V., Wong, K.Y., Magor, G., et al. High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci. Rep., 6, 2016, 28990.
16. Han, B., Sheng, B., Zhang, Z., Pu, A., Yin, J., Wang, Q., Yang, K., Sun, L., Yu, M., Qiu, Y., et al. Aryl hydrocarbon receptor activation in intestinal obstruction ameliorates intestinal barrier dysfunction via suppression of MLCK-MLC phosphorylation pathway. Shock 46 (2016), 319–328.
17. Hao, N., Whitelaw, M.L., The emerging roles of AhR in physiology and immunity. Biochem. Pharmacol. 86 (2013), 561–570.
18. Johnson, A.M., Costanzo, A., Gareau, M.G., Armando, A.M., Quehenberger, O., Jameson, J.M., Olefsky, J.M., High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One, 10, 2015, e0122195.
19. Korecka, A., Dona, A., Lahiri, S., Tett, A.J., Al-Asmakh, M., Braniste, V., D'Arienzo, R., Abbaspour, A., Reichardt, N., Fujii-Kuriyama, Y., et al. Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism. NPJ Biofilms Microbiomes, 2, 2016, 16014.
20. Lamas, B., Richard, M.L., Leducq, V., Pham, H.P., Michel, M.L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T.W., Natividad, J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22 (2016), 598–605.
21. Lamas, B., Natividad, J.M., Sokol, H., Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol. 11 (2018), 1024–1038.
22. Lan, H., Lin, H.V., Wang, C.F., Wright, M.J., Xu, S., Kang, L., Juhl, K., Hedrick, J.A., Kowalski, T.J., Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. Br. J. Pharmacol. 165 (2012), 2799–2807.
23. Laval, L., Martin, R., Natividad, J.N., Chain, F., Miquel, S., Desclée de Maredsous, C., Capronnier, S., Sokol, H., Verdu, E.F., van Hylckama Vlieg, J.E., et al. Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes 6 (2015), 1–9.
24. Leavy, O., Mucosal immunology: the ‘AHR diet’ for mucosal homeostasis. Nat. Rev. Immunol., 11, 2011, 806.
25. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102 (2005), 11070–11075.
26. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
27. Li, Y., Innocentin, S., Withers, D.R., Roberts, N.A., Gallagher, A.R., Grigorieva, E.F., Wilhelm, C., Veldhoen, M., Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147 (2011), 629–640.
28. Luck, H., Tsai, S., Chung, J., Clemente-Casares, X., Ghazarian, M., Revelo, X.S., Lei, H., Luk, C.T., Shi, S.Y., Surendra, A., et al. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents. Cell Metab. 21 (2015), 527–542.
29. McDonald, D., Price, M.N., Goodrich, J., Nawrocki, E.P., DeSantis, T.Z., Probst, A., Andersen, G.L., Knight, R., Hugenholtz, P., An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6 (2012), 610–618.
30. Murray, I.A., Patterson, A.D., Perdew, G.H., Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer 14 (2014), 801–814.
31. Prendergast, G.C., Chang, M.Y., Mandik-Nayak, L., Metz, R., Muller, A.J., Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases. Curr. Med. Chem. 18 (2011), 2257–2262.
32. Qiu, J., Heller, J.J., Guo, X., Chen, Z.M., Fish, K., Fu, Y.X., Zhou, L., The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36 (2012), 92–104.
33. Richards, P., Pais, R., Habib, A.M., Brighton, C.A., Yeo, G.S., Reimann, F., Gribble, F.M., High fat diet impairs the function of glucagon-like peptide-1 producing L-cells. Peptides 77 (2016), 21–27.
34. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
35. Schirmer, M., Smeekens, S.P., Vlamakis, H., Jaeger, M., Oosting, M., Franzosa, E.A., Ter Horst, R., Jansen, T., Jacobs, L., Bonder, M.J., et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167 (2016), 1125–1136.e8.
36. Schmieder, R., Edwards, R., Quality control and preprocessing of metagenomic datasets. Bioinformatics 27 (2011), 863–864.
37. Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9 (2012), 671–675.
38. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
39. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., Flier, J.S., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006), 3015–3025.
40. Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
41. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
42. Venkatesh, M., Mukherjee, S., Wang, H., Li, H., Sun, K., Benechet, A.P., Qiu, Z., Maher, L., Redinbo, M.R., Phillips, R.S., et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41 (2014), 296–310.
43. Wada, T., Sunaga, H., Miyata, K., Shirasaki, H., Uchiyama, Y., Shimba, S., Aryl hydrocarbon receptor plays protective roles against high fat diet (HFD)-induced hepatic steatosis and the subsequent lipotoxicity via direct transcriptional regulation of Socs3 gene expression. J. Biol. Chem. 291 (2016), 7004–7016.
44. Wang, X., Ota, N., Manzanillo, P., Kates, L., Zavala-Solorio, J., Eidenschenk, C., Zhang, J., Lesch, J., Lee, W.P., Ross, J., et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514 (2014), 237–241.
45. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.